Samtidig behandling med − anti- blodplade stoffer udover acetylsalicylsyre, så som ticlopidin eller clopidogrel, − GpIIb/ IIIa receptor antagonister, så som eptifibatid, irofiban eller abciximab, − andre trombin inhibitorer, så som lav molekulær vægt hepariner − er ikke blevet vurderet.
Concomitant use with – antiplatelet agents other than acetylsalicylic acid, such as ticlopidine or clopidogrel, – GpIIb/ IIIa receptor antagonists such as eptifibatide, tirofiban, or abciximab, – other thrombin inhibitors such as low molecular weight heparins has not been assessed.